Status:
UNKNOWN
Programmed Intermittent Bolus During Continuous Interscalene Nerve Block for Shoulder Arthroplasty
Lead Sponsor:
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Conditions:
Shoulder Arthroplasty
Shoulder Osteoarthritis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
A new infusion strategy named the 'programmed intermittent bolus' (PIB) technique delivers the hourly dose within minutes compared to the traditional infusion that delivers such dose over an hour. The...
Detailed Description
Local anesthetics are often given in a continuous fashion to block specific nerves after an operation for pain control. A new infusion strategy named the 'programmed intermittent bolus' (PIB) techniqu...
Eligibility Criteria
Inclusion
- Adult patients
- American Society of Anesthesiologists (ASA) Physical Status I to III
Exclusion
- Body mass index (BMI) \> 40
- Not able to communicate in ENglish
- Unable to obtain consent
- Infection over site of placement
- Severe respiratory disease
- Cognitive or psychiatric history that would make it difficult to assess pain score
- Complex regional pain syndrome
- Chronic pain condition such as fibromyalgia, neuropathic pain
- Preoperative opioid use greater than the equivalent of morphine 50 mg PO daily
- Allergy to any of the study drug
- Coagulopathy
Key Trial Info
Start Date :
January 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT03268837
Start Date
January 1 2022
End Date
December 1 2024
Last Update
October 3 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St. Joseph's Health Care London
London, Ontario, Canada, N6A 4V2